Cutting-edge technology meets compassionate care
We learn why Busamed Hillcrest Oncology Centre is considered the local gateway to top-tier radiation therapy services.
You can listen to this article below, or by using your favourite podcast player at pod.link/oncologybuddies
Busamed Hillcrest Oncology Centre was established in 2018 with a focus on enhancing patient well-being. While specialising in breast cancer, our dedicated team extends its expertise to treat various cancers, including head and neck, lung, prostate, and other sites.
Community-centric excellence
Having assisted thousands of patients and their families, our commitment is unwavering. We deliver exceptional treatment using advanced technology in a comforting and easily accessible environment. This reflects our pride in showcasing the collective strength of institutions collaborating to uplift the health of our community.
Cutting-edge innovation
Our dedication to advancing patient care leads us to continually invest in innovative technology at Busamed Hillcrest Oncology. Our mission is clear: to provide an excellent standard of care and exceptional treatment close to home.
We were the first in Sub-Saharan Africa to offer the Halcyonā¢ Radiation Therapy System, a revolutionary technology capable of delivering high-quality radiation therapy for various cancer types.
The Halcyonā¢ linear accelerator, resembling a CT scanner, prioritises your comfort. Its design minimises noise and vibration, and a two-way intercom facilitates communication with your radiation therapist. The extra-large circular opening adds to the overall comfort of your experience.
Precision and protection with AlignRTĀ® InBoreā¢
In pursuit of advancing the precision and safety standards in radiation therapy on the Halcyonā¢ platform and aligning with our commitment to pioneering InBoreā¢ treatment delivery, we have strategically invested in the cutting-edge AlignRTĀ® InBoreā¢ technology. Notably, we are the inaugural institution in Africa to incorporate this state-of-the-art solution. This ground-breaking technology seamlessly integrates precision, safety, and workflow efficiency, thereby augmenting the overall treatment experience for our patients.
AlignRTĀ® InBoreā¢ incorporates a discreetly placed miniaturised camera within the Halcyonā¢ treatment ring, ensuring sub-millimetric accuracy in patient monitoring. Through a unique projection of a speckled pattern on your skin, thousands of reference points are utilised by AlignRTĀ®, providing unparalleled precision. The captured imaging information is seamlessly integrated into a software programme, allowing real-time and accurate tracking throughout your setup and radiotherapy treatment. This ensures immediate alerting if any movement deviates from the optimal position.Ā
Tattoo and mark-free treatment
Traditional radiation therapy requires patients to receive small, often permanent tattoos on their skin to help the radiation therapist position them for treatment. AlignRTĀ® InBoreā¢ projects thousands of virtual tattoos on the surface of your body to monitor your positioning with sub millimetric accuracy.
Using AlignRTĀ® InBoreā¢, Busamed Hillcrest Oncology Centre has joined a growing number of premiere radiation oncology centres around the world offering tattoo and mark-free treatments.
This technology enhances setup accuracy by continuously monitoring a patient’s movements during treatment delivery, thereby improving the overall treatment experience. Additionally, this technology serves as a platform to notably decrease cardiac doses for patients undergoing radiotherapy to the left breast.
Proven as a game-changer for treatments such as Deep Inspiration Breath Hold (DIBH) and stereotactic procedures, AlignRTĀ® InBoreā¢ offers an unprecedented level of treatment accuracy that prioritises your comfort. Embrace the future of patient care at Busamed Hillcrest Oncology Centre with AlignRTĀ® InBoreā¢, where technology meets compassion for a personalised and enhanced treatment journey.
MEET THE EXPERT – Dr Ziad Seedat
Dr Ziad Seedat attended the University of Natal and Edinburgh and joined Hopelands in 2004. His special interests are in head and neck stereotactic radiosurgery. He is a director and executive committee member of the South African Oncology Consortium, has served on the steering committee of the South African Society of Clinical and Radiation Oncologists, and isĀ a member of the European Society for Medical Oncology and the American Society for Radiation Oncology.
This article was sponsored by Vision RT
Header image supplied
